Control of immunopathology during chikungunya virus infection

Journal of Allergy and Clinical Immunology

Volumn 135, Issue 4, 2015, Pages 846-855

  Petitdemange, Caroline ^a   Wauquier, Nadia ^a,b   Vieillard, Vincent ^a,c,d  

^a SORBONNE UNIVERSITÉ   (France)

^b METABIOTA INC   (United States)

^c INSERM   (France)

^d Assistance publique Hôpitaux de Paris   (France)

Author keywords

Chikungunya virus; immune responses; immunotherapy; vaccination

Indexed keywords

ANALGESIC AGENT; ANTIPYRETIC AGENT; ANTIRHEUMATIC AGENT; ANTIVIRUS AGENT; CORTICOSTEROID; VIRUS VACCINE;

ACUTE DISEASE; ADAPTIVE IMMUNITY; CHIKUNGUNYA; CHRONICITY; DISEASE CONTROL; DISEASE SEVERITY; FLUID THERAPY; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOTHERAPY; INNATE IMMUNITY; PATHOGENESIS; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE; VIRUS CELL INTERACTION; CHIKUNGUNYA FEVER; CHIKUNGUNYA VIRUS; IMMUNOLOGY;

ADAPTIVE IMMUNITY; CHIKUNGUNYA FEVER; CHIKUNGUNYA VIRUS; HUMANS; IMMUNITY, INNATE; IMMUNOTHERAPY; VIRAL VACCINES;

EID: 84926219807     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.01.039     Document Type: Article

References (86)

1. W.H. Lumsden An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. II. General description and epidemiology Trans R Soc Trop Med Hyg 49 1955 33 57
2. M.C. Robinson An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53: clinical features Trans R Soc Trop Med Hyg 49 1955 28
3. A. Suhrbier, M.C. Jaffar-Bandjee, and P. Gasque Arthritogenic alphaviruses-an overview Nat Rev Rheumatol 8 2012 420 429
4. M. Solignat, B. Gay, S. Higgs, L. Briant, and C. Devaux Replication cycle of chikungunya: a re-emerging arbovirus Virology 393 2009 183 197
5. O. Schwartz, and M.L. Albert Biology and pathogenesis of chikungunya virus Nat Rev Microbiol 8 2010 491 500
6. L.A. Silva, S. Khomandiak, A.W. Ashbrook, R. Weller, M.T. Heise, and T.E. Morrison A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization J Virol 88 2014 2385 2397
7. P. Spuul, G. Balistreri, K. Hellström, A.V. Golubtsov, E. Jokitalo, and T. Ahola Assembly of alphavirus replication complexes from RNA and protein components in a novel trans-replication system in mammalian cells J Virol 85 2011 4739 4751
8. J. Waldock, N.L. Chandra, J. Lelieveld, Y. Proestos, E. Michael, and G. Christophides The role of environmental variables on Aedes albopictus biology and chikungunya epidemiology Pathog Glob Health 107 2013 224 241
9. K.A. Tsetsarkin, C.E. McGee, S.M. Volk, D.L. Vanlandingham, S.C. Weaver, and S. Higgs Epistatic roles of E2 glycoprotein mutations in adaption of chikungunya virus to Aedes albopictus and Ae. aegypti mosquitoes PLoS One 4 2009 e6835
10. K.A. Tsetsarkin, R. Chen, R. Yun, S.L. Rossi, K.S. Plante, and M. Guerbois Multi-peaked adaptive landscape for chikungunya virus evolution predicts continued fitness optimization in Aedes albopictus mosquitoes Nat Commun 5 2014 4084
11. K.A. Tsetsarkin, R. Chen, M.B. Sherman, and S.C. Weaver Chikungunya virus: evolution and genetic determinants of emergence Curr Opin Virol 1 2011 310 317
12. G. Borgherini, P. Poubeau, F. Staikowsky, M. Lory, N. Le Moullec, and J.P. Becquart Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients Clin Infect Dis 44 2007 1401 1407
13. P. Renault, J.L. Solet, D. Sissoko, E. Balleydier, S. Larrieu, and L. Filleul A major epidemic of chikungunya virus infection on Reunion Island, France, 2005-2006 Am J trop Med Hyg 77 2007 727 731
14. V.A. Arankulle, S. Shrivastava, S. Chrian, R.S. Gunjikar, A.M. Walimbe, and S.M. Jadhav Genetic divergence of chikungunya viruses in India (1963-2006) with special reference to the 2005-2006 explosive epidemic J Gen Virol 88 2007 1967 1976
15. E.M. Leroy, D. Nkoghe, B. Ollomo, C. Nze-Nkogue, P. Becquart, and G. Grard Concurrent chikungunya and dengue virus infections during simultaneous outbreaks, Gabon, 2007 Emerg Infect Dis 15 2009 591 593
16. M. Caron, C. Paupy, G. Grard, P. Becquart, I. Mombo, and B.B. Nso Recent introduction and rapid dissemination of Chikungunya virus and Dengue virus serotype 2 associated with human and mosquito coinfections in Gabon, central Africa Clin Infect Dis 55 2012 e45 e53
17. D. Nkoghe, R.F. Kassa, M. Caron, G. Grard, I. Mombo, and B. Bikié Clinical forms of chikungunya in Gabon, 2010 PLoS Negl Trop Dis 6 2012 e1517
18. R. Ansumana, K.H. Jacobsen, T.A. Leski, A.L. Covington, U. Bangura, and M.H. Hodges Reemergence of chikungunya virus in Bo, Sierra Leone Emerg Infect Dis 19 2013 1108 1110
19. G. Rezza, L. Nicoletti, R. Angelini, R. Romi, A.C. Finarelli, and M. Panning Infection with chikungunya virus in Italy: an outbreak in a temperate region Lancet 370 2007 1840 1846
20. I. Leparc-Goffart, A. Nougairede, S. Cassadou, C. Prat, and X. de Lamballerie Chikungunya in the Americas Lancet 383 2014 514
21. J.E. Staples, and M. Fischer Chikungunya virus in the Americas-what a vectorborne pathogen can do N Engl J Med 371 2014 887 889
22. B. Olowokure, L. Francis, K. Polson-Edwards, R. Nasci, P. Quénel, and S. Aldighieri The Caribbean response to chikungunya Lancet Infect Dis 14 2014 1039 1040
23. K.B. Gibney, M. Fischer, H.E. Prince, L.D. Kramer, K. St George, and O.L. Kosoy Chikungunya fever in the United States: a fifteen year review of cases Clin Infect Dis 52 2011 e121 e126
24. N.P. Lindsey, H.E. Prince, O. Kosoy, J. Laven, S. Messenger, and J.E. Staples Chikungunya virus infections among travelers-United States, 2010-2013 Am J Trop Med Hyg 92 2015 82 87
25. N. Palha, F. Guivel-Benhassine, V. Briolat, G. Lutfalla, M. Sourisseau, and F. Ellett Real-time whole-body visualization of Chikungunya Virus infection and host interferon response in zebrafish PLoS Pathog 9 2013 e1003619
26. A. Chow, Z. Her, E.K. Ong, J.M. Chen, F. Dimatatac, and D.J. Kwek Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor J Infect Dis 203 2011 149 157
27. Y.S. Leo, A.L. Chow, L.K. Tan, D.C. Lye, L. Lin, and L.C. Ng Chikungunya outbreak, Singapore, 2008 Emerg Infect Dis 15 2009 836 837
28. S.D. Thiberville, V. Boisson, J. Gaudart, F. Simon, A. Flahault, and X. de Lamballerie Chikungunya fever: a clinical and virological investigation of outpatients on Reunion Island, South-West Indian Ocean PLoS Negl Trop Dis 7 2013 e2004
29. J.J. Hoarau, M.C. Jaffar Bandjee, P. Krejbich Trotot, T. Das, G. Li-Pat-Yuen, and B. Dassa Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response J Immunol 184 2010 5914 5927
30. N. Wauquier, P. Becquart, D. Nkoghe, C. Padilla, A. Ndjoyi-Mbiguino, and E.M. Leroy The acute phase of chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation J Infect Dis 204 2011 115 123
31. P.A. Rudd, J. Wilson, J. Gardner, T. Larcher, C. Babarit, and T.T. Le Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock J Virol 86 2012 9888 9898
32. J.E. Staples, R.F. Breiman, and A.M. Powers Chikungunya fever: an epidemiological review of a re-emerging infectious disease Clin Infect Dis 49 2009 942 948
33. L. Dupuis-Maguiraga, M. Noret, S. Brun, R. Le Grand, G. Gras, and P. Roques Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia PLoS Negl Trop Dis 6 2012 e1446
34. L.F. Ng, A. Chow, Y.J. Sun, D.J. Kwek, P.L. Lim, and F. Dimatatac IL-1beta, IL-6, and RANTES as biomarkers of Chikungunya severity PLoS One 4 2009 e4261
35. A.A. Kelvin, D. Banner, G. Silvi, M.L. Moro, N. Spataro, and P. Galbani Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity PLoS Negl Trop Dis 5 2011 e1279
36. A. Venugopalan, R.P. Ghorpade, and A. Chopra Cytokines in acute chikungunya PLoS One 9 2014 e111305
37. K. Labadie, T. Larcher, C. Joubert, A. Mannioui, B. Delache, and L. Guigand Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages J Clin Invest 120 2010 894 906
38. D. Sissoko, D. Malvy, K. Ezzedine, P. Renault, F. Moscetti, and M. Ledrans Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period PLoS Negl Trop Dis 3 2009 e389
39. M.R. Sebastian, R. Lodha, and S.K. Kabra Chikungunya infection in children Indian J Pediatr 76 2009 185 189
40. P. Lewthwaite, R. Vasanthapuram, J.C. Osborne, A. Begum, J.L. Plank, and M.V. Shankar Chikungunya virus and central nervous system infections in children, India Emerg Infect Dis 15 2009 329 331
41. A. Economopoulou, M. Dominguez, B. Helynck, D. Sissoko, O. Wichmann, and P. Quenel Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Réunion Epidemiol Infect 137 2009 534 541
42. P. Gérardin, G. Barau, A. Michault, M. Bintner, H. Randrianaivo, and G. Choker Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion PLoS Med 5 2008 e60
43. F.J. Burt, M.S. Rolph, N.E. Rulli, S. Mahalingam, and M.T. Heise Chikungunya: a re-emerging virus Lancet 379 2012 662 671
44. I. Akhrymuk, S.V. Kulemzin, and E.I. Frolova Evasion of the innate immune response: the Old World alphavirus nsP2 protein induces rapid degradation of Rpb1, a catalytic subunit of RNA polymerase II J Virol 86 2012 7180 7191
45. M. Sourisseau, C. Schilte, N. Casartelli, C. Trouillet, F. Guivel-Benhassine, and D. Rudnicka Characterization of reemerging chikungunya virus PLoS Pathog 3 2007 e89
46. S. Jost, and M. Altfeld Control of human viral infections by natural killer cells Annu Rev Immunol 31 2013 163 194
47. C. Petitdemange, P. Becquart, N. Wauquier, V. Béziat, P. Debré, and E.M. Leroy Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity PLoS Pathog 7 2011 e1002268
48. K.J. Malmberg, V. Beziat, and H.G. Ljunggren Spotlight on NKG2C and the human NK-cell response to CMV infection Eur J Immunol 42 2012 3141 3145
49. S. Kulkarni, M.P. Martin, and M. Carrington The Yin and Yang of HLA and KIR in human disease Semin Immunol 20 2008 343 352
50. C. Petitdemange, N. Wauquier, J.M. Jacquet, I. Theodorou, E. Leroy, and V. Vieillard Association of HLA class-I and inhibitory KIR genotypes in Gabonese patients infected by Chikungunya or Dengue type-2 viruses PLoS One 9 2014 e108798
51. K.M. Long, A.C. Whitmore, M.T. Ferris, G.D. Sempowski, C. McGee, and B. Trollinger Dendritic cell immunoreceptor regulates Chikungunya virus pathogenesis in mice J Virol 87 2013 5697 5706
52. S. Kumar, M.C. Jaffar-Bandjee, C. Giry, L. Connen de Kerillis, A. Merits, and P. Gasque Mouse macrophage innate immune response to Chikungunya virus infection Virol J 9 2012 313
53. Z. Her, B. Malleret, M. Chan, E.K. Ong, S.C. Wong, and D.J. Kwek Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response J Immunol 184 2010 5903 5913
54. N. Litzba, I. Schuffenecker, H. Zeller, C. Drosten, P. Emmerich, and R. Charrel Evaluation of the first commercial chikungunya virus indirect immunofluorescence test J Virol Methods 149 2008 175 179
55. Y.W. Kam, F.M. Lum, T.H. Teo, W.W. Lee, D. Simarmata, and S. Harjanto Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein EMBO Mol Med 4 2012 330 343
56. F.M. Lum, T.H. Teo, W.W. Lee, Y.W. Kam, L. Rénia, and L.F. Ng An essential role of antibodies in the control of Chikungunya virus infection J Immunol 190 2013 6295 6302
57. Z. Her, T.S. Teng, J.J. Tan, T.H. Teo, Y.W. Kam, and F.M. Lum Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response EMBO Mol Med 7 2014 24 41
58. Y.W. Kam, W.W. Lee, D. Simarmata, R. Le Grand, H. Tolou, and A. Merits Unique epitopes recognized by antibodies induced in Chikungunya virus-infected non-human primates: implications for the study of immunopathology and vaccine development PLoS One 9 2014 e95647
59. Y.W. Kam, D. Simarmata, A. Chow, Z. Her, T.S. Teng, and E.K. Ong Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection J Infect Dis 205 2012 1147 1154
60. N. Kishishita, M. Sasayama, N. Takeda, A. Sa-Ngasang, A. Anuegoonpipat, and S. Anantapreecha Neutralization activity of patient sera collected during 2008-2009 chikungunya outbreak in Thailand J Clin Microbiol 53 2015 184 190
61. N. Nitatpattana, K. Kanjanopas, S. Yoksan, W. Satimai, N. Vongba, and S. Langdatsuwan Long-term persistence of Chikungunya virus neutralizing antibodies in human populations of North Eastern Thailand Virol J 11 2014 183
62. J.J. Hoarau, F. Gay, O. Pellé, A. Samri, M.C. Jaffar-Bandjee, and P. Gasque Identical strength of the T cell responses against E2, nsP1 and capsid CHIKV proteins in recovered and chronic patients after the epidemics of 2005-2006 in La Reunion Island PLoS One 8 2013 e84695
63. T.E. Morrison, L. Oko, S.A. Montgomery, A.C. Whitmore, A.R. Lotstein, and B.M. Gunn A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence Am J Pathol 178 2011 32 40
64. T.H. Teo, F.M. Lum, C. Claser, V. Lulla, A. Lulla, and A. Merits A pathogenic role for CD4+ T cells during Chikungunya virus infection in mice J Immunol 190 2013 259 269
65. N. Komatsu, and H. Takayanagi Autoimmune arthritis: the interface between the immune system and joints Adv Immunol 115 2012 45 71
66. T. Couderc, N. Khandoudi, M. Grandadam, C. Visse, N. Gangneux, and S. Bagot Prophylaxis and therapy for Chikungunya virus infection J Infect Dis 200 2009 516 523
67. L. Warter, C.Y. Lee, R. Thiagarajan, M. Grandadam, S. Lebecque, and R.T. Lin Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency J Immunol 186 2011 3258 3264
68. P. Pal, K.A. Dowd, J.D. Brien, M.A. Edeling, S. Gorlatov, and S. Johnson Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus PLoS Pathog 9 2013 e1003312
69. J. Fric, S. Bertin-Maghit, C.I. Wang, A. Nardin, and L. Warter Use of human monoclonal antibodies to treat chikungunya virus infection J Infect Dis 207 2013 319 322
70. N.E. Rulli, M.S. Rolph, A. Srikiatkhachorn, S. Anantapreecha, A. Guglielmotti, and S. Mahalingam Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis J Infect Dis 204 2011 1026 1030
71. W. Chen, S.S. Foo, A. Taylor, A. Lulla, A. Merits, and L. Hueston Bindarit, an inhibitor of monocyte chemotactic proteins (MCPs) synthesis, protects against bone loss induced by Chikungunya virus infection J Virol 89 2015 581 593
72. A. White, S. Berman, and J.P. Lowenthal Comparative immunogenicities of chikungunya vaccines propagated in monkey kidney monolayers and chick embryo suspension cultures Appl Microbiol 23 1972 951 952
73. K. Plante, E. Wang, C.D. Partidos, J. Weger, R. Gorchakov, and K. Tsetsarkin Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism PLoS Pathog 7 2011 e1002142
74. D. Hallengärd, M. Kakoulidou, A. Lulla, B.M. Kummerer, D.X. Johansson, and M. Mutso Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice J Virol 88 2014 2858 2866
75. P. van den Doel, A. Volz, J.M. Roose, V.D. Sewbalaksing, G.P. Pijlman, and I. van Middelkoop Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge PLoS Negl Trop Dis 8 2014 e3101
76. J. García-Arriaza, V. Cepeda, D. Hallengard, C.O. Sorzano, B.M. Kummerer, and P. Liljeström A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against Chikungunya infection J Virol 88 2014 3527 3547
77. K. Mallilankaraman, D.J. Shedlock, H. Bao, O.U. Kawalekar, P. Fagone, and A.A. Ramanathan A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates PLoS Negl Trop Dis 5 2011 e928
78. W. Akahata, Z.Y. Yang, H. Andersen, S. Sun, H.A. Holdaway, and W.P. Kong A virus-like particle vaccine for epidemic chikungunya virus protects nonhuman primates against infection Nat Med 16 2010 334 338
79. L.J. Chang, K.A. Dowd, F.H. Mendoza, J.G. Saunders, S. Sitar, and S.H. Plummer Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial Lancet 384 2014 2046 2052
80. N.H. Levitt, H.H. Ramsburg, S.E. Hasty, P.M. Repik, F.E. Cole Jr., and H.W. Lupton Development of an attenuated strain of chikungunya virus for use in vaccine production Vaccine 4 1986 157 162
81. R. Gorchakov, E. Wang, G. Leal, N.L. Forrester, K. Plante, and S.L. ROssi Attenuation of chikungunya virus vaccine strain 181/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein J Virol 86 2012 6084 6096
82. C.Y. Lee, Y.W. Kam, J. Fric, B. Malleret, E.G. Koh, and C. Prakash Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutants PLoS Pathog 7 2011 e1002390
83. P. Pal, J.M. Fox, D.W. Hawman, Y.J. Huang, I. Messaoudi, and C. Kreklywich Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes J Virol 88 2014 8213 8226
84. K. Khan, I. Bogoch, J.S. Brownstein, J. Miniota, A. Nicolucci, and W. Hu Assessing the origin of and potential for international spread of chikungunya virus from the Caribbean PLoS Curr Outbreaks 6 Edition 1 2014;June
85. S.C. Weaver Arrival of chikungunya virus in the new world: prospects for spread and impact on public health PLoS Negl Trop Dis 8 2014 e2921
86. M. Baba, C.H. Logue, B. Oderinde, H. Abdulmaleek, J. Williams, and J. Lewis Evidence of arbovirus co-infection in suspected febrile malaria and typhoid patients in Nigeria J Infect Dev Ctries 7 2013 51 59